Evidence map›Paper›PMID 36189170›Full record

ArticleDEN open2023

Assessment of photodynamic therapy as a salvage treatment for local failure after chemoradiotherapy or radiotherapy for esophageal cancer in patients aged 80 years or older.

Michiko Nishikawa, Yoshinobu Yamamoto, Saeko Kushida, Taku Hirabayashi, Syunta Tanaka, Naoki Takegawa, Takuya Mimura, Hidetaka Tsumura, Ikuya Miki, Masahiro Tsuda

Abstract read
In one paragraph

Article in DEN open, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Aging and cancer: current understandings and future perspectives.Signal transduction and targeted therapy · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Michiko NishikawaDepartment of Gastroenterological Oncology Hyogo Cancer Center Hyogo Japan.ORCID https://orcid.org/0000-0002-4259-3583
Yoshinobu YamamotoDepartment of Gastroenterological Oncology Hyogo Cancer Center Hyogo Japan.
Saeko KushidaDepartment of Gastroenterological Oncology Hyogo Cancer Center Hyogo Japan.
Taku HirabayashiDepartment of Gastroenterological Oncology Hyogo Cancer Center Hyogo Japan.
Syunta TanakaDepartment of Gastroenterological Oncology Hyogo Cancer Center Hyogo Japan.
Naoki TakegawaDepartment of Gastroenterological Oncology Hyogo Cancer Center Hyogo Japan.
Takuya MimuraDepartment of Gastroenterology Kakogawa Central City Hospital Hyogo Japan.
Hidetaka TsumuraDepartment of Gastroenterological Oncology Hyogo Cancer Center Hyogo Japan.
Ikuya MikiDepartment of Gastroenterological Oncology Hyogo Cancer Center Hyogo Japan.
Masahiro TsudaDepartment of Gastroenterological Oncology Hyogo Cancer Center Hyogo Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Chemoradiotherapy (CRT) or radiotherapy (RT) alone is often the treatment of choice for elderly patients with esophageal cancer with the expectation of organ preservation. However, salvage treatment remains a problem when endoscopic resection is not indicated for local failure after CRT/RT. Photodynamic therapy (PDT) is indicated for local failure after CRT/RT, but there are few reports on its efficacy and safety in elderly patients. This study aimed to assess the outcome of PDT for local failure after CRT/RT for esophageal cancer in elderly patients. Methods: This retrospective single-center study included 42 patients who first underwent PDT between April 2013 and June 2021. Patients aged ≥80 and <80 years were classified into the elderly and nonelderly groups, respectively. Local complete response rate, overall survival, progression-free survival, and incidence of adverse events related to PDT were compared retrospectively between the groups. Results: The local complete response rate was 93.3% in the elderly group and 85.7 in the non-elderly group. The 2-year overall survival rate was 68.6% and 72.5%, and the 2-year progression-free survival rate was 49.5% and 70.0% in the elderly and nonelderly groups, respectively. There was no significant difference in any of these outcomes between the groups. In terms of adverse events, pneumonia and delirium tended to occur more frequently in the elderly group, but there were no serious adverse events in either group. Conclusion: The outcome of salvage PDT in the local control was comparable between the elderly and nonelderly patients for local failure after CRT/RT for esophageal cancer.

Indexed as

agedchemoradiotherapyesophageal neoplasmsphotochemotherapysalvage therapy

Identifiers

PMID36189170
PMCPMC9510438

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.